Efficacy of β-blocker in the treatment of 90 senile patients with chronic heart failure
10.3969/j.issn.1009-0754.2016.02.019
- VernacularTitle:β-受体阻滞剂治疗老年慢性心力衰竭患者90例疗效分析
- Author:
Yehua TANG
1
;
Qixia JIANG
;
Yanmin ZHAO
;
Gaozhong HUANG
Author Information
1. 第二军医大学附属长征医院心血管内科
- Keywords:
β-blocker;
Chronic heart failure;
Senile patient
- From:
Journal of Navy Medicine
2016;37(2):160-161,185
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the efficacy of β-blocker in the treatment of senile patients with chronic heart failure. Methods Ninety senile patients with chronic congestive heart failure ( age>65 years) were selected for the study.Of all the cases, 48 were given routine anti-heart failure therapy and were set as the control group, while another 42 cases were set as the treatment group, that was given oral Betaloc at a dosage of 6.25 mg/once, twice a day, with an increased dosage of twice as much as the original dosage within 2 weeks.Then, close observation was made on the therapeutic efficacy.Results Total effective rate for the improvement of clinical symptoms in the treatment group was 92.9%, which was significantly higher than that of the control group (75%).In addi-tion, as compared with the patients in the control group, the heart rate of the patients at rest in the treatment group following medication of Betaloc was significantly decreased, and the consumption of digoxin and amiodarone was decreased also.Statistical significance could be seen when comparisons were made between the 2 groups (P<0.05).Conclusion Prolonged and standardized application ofβ-bloc-ker could significantly improve the clinical symptoms of senile patients with chronic heart failure, thus facilitating to reach the desired target heart rate, decreasing mortality and the incidence of complications.
